Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-01-04 @ 6:42 PM
Study NCT ID:
NCT03303105
Status:
COMPLETED
Last Update Posted:
2023-02-17
First Post:
2017-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-16
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-02
First Submit QC Date:
None
Study First Post Date:
2017-10-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-27
Results First Submit QC Date:
None
Results First Post Date:
2021-07-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-16
Last Update Post Date:
2023-02-17
Last Update Post Date Type:
ACTUAL